EarlySense
EarlySense develops a contact-free continuous patient monitoring system for general care hospital patients, tracking heart rate, respiratory rate, and motion without physical contact and delivering real-time alerts to nursing staff for early deterioration, fall, and pressure ulcer prevention.
- Company typePrivate
- Founded2004
- HeadquartersRamat Gan, Israel
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What EarlySense does
EarlySense is an Israel-based healthcare technology company, founded in 2004 and headquartered in Ramat Gan, that has developed a contact-free continuous patient monitoring system for general care hospital settings. The system's proprietary sensor technology tracks heart rate, respiratory rate, and patient motion without physical contact with the patient, and delivers real-time alerts to nursing staff through central stations, large screens, and handheld devices. It is positioned to address three clinical use cases — early detection of patient deterioration, fall prevention, and pressure ulcer prevention — in general care wards where patients are otherwise checked only every four to six hours by nursing staff.
The company operates an enterprise B2B sales motion, selling hardware-based monitoring systems directly to healthcare facilities. Pricing is not publicly disclosed. EarlySense has raised approximately $131 million across 11 funding rounds since 2005, with strategic investors including Hill-Rom (a major hospital bed OEM), Wells Fargo Strategic Capital, Samsung Ventures, Mitsui & Co, and Welch Allyn participating alongside recurring financial investors Pitango VC and JK&B Capital. The most recent disclosed round was $39 million in January 2019, which valued the company at $325 million post-money on a $260 million pre-money basis. The company operates with approximately 68 employees under co-founder and CEO Avner Halperin, with CTO Guy Merger overseeing R&D and a dedicated VP of Clinical and Regulatory Affairs indicating active medical device compliance work. The recurring presence of hospital infrastructure and medical device strategics in the cap table points to embedded distribution channels rather than a pure standalone vendor model.
No revenue figure, named customer accounts, post-2019 funding event, or subsequent product launch are disclosed in the available source data, which limits visibility into current commercial scale and momentum.
EarlySense firmographics
Firmographics- Name
- EarlySense
- Website
- https://earlysense.com
- Company type
- Private
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- EarlySense develops a contact-free continuous patient monitoring system for general care hospital patients, tracking heart rate, respiratory rate, and motion without physical contact and delivering real-time alerts to nursing staff for early deterioration, fall, and pressure ulcer prevention.
- Ownership category
- akta.pro rank
EarlySense industry classification
Industry- Product category
- Patient Monitoring Systems
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Vital Signs Monitoring (Multi-parameter, Spot-Check & Continuous) (HLAHACAA)
- akta.pro secondary industries
- Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI), Fall Detection, Safety & Emergency Response (PERS, Smart Home Health Sensors) (HLAHACAG)
Keywords
Where EarlySense is headquartered
LocationHeadquarters
- HQ city
- Ramat Gan
- HQ country
- Israel
- HQ region
- Middle East
Markets served
EarlySense business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations
Revenue model
- Healthcare Monitoring System Sales: Sale of continuous patient monitoring systems to healthcare facilities with real-time alerting capabilities for clinical use in general care settings.
Go-to-market motion1 record
EarlySense product offering
Product offeringCore offering
EarlySense develops and sells EverOn, a contact-free continuous patient monitoring system that tracks heart rate, respiratory rate, and motion without physical contact. The system is designed for general care hospital patients, delivering real-time alerts to nursing staff through central stations, large screens, and handheld devices to enable early detection of patient deterioration, fall prevention, and pressure ulcer prevention.
Product overview
EarlySense offers a single unified continuous patient monitoring system designed for general care patients. The system non-contactedly tracks heart rate, respiratory rate, and motion, delivering real-time alerts to nursing staff via central stations, large screens, and handheld devices. It serves three primary clinical use cases: early detection of patient deterioration, fall prevention, and pressure ulcer prevention.
Differentiator
Problem solved
Functional benefit
Products and services
- EarlySense Continuous Patient Monitoring System (EverOn)
Companies that use EarlySense
Customer profileSegments1 record
Ideal customer profiles1 record
EarlySense technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
EarlySense partnerships and signals
Strategic signalScale indicators3 records
Recent moves4 records
Expansion highlights4 records
EarlySense competitors and assessment
Company assessmentDirect peers
- Caretaker Medical: Caretaker Medical makes a continuous, non-invasive "cNIBP" vital signs monitor that tracks blood pressure, heart rate, and respiratory rate without cuffs or contact. It is the closest direct competitor to EarlySense's contact-free ward-monitoring approach.
- Masimo: Masimo is a global patient monitoring leader with continuous SpO2, respiratory, and pulse-rate sensors used across general care, step-down, and ICU settings. Its wearable and bedside monitoring portfolio competes head-to-head with EarlySense in the same hospital vital-signs category.
- Nihon Kohden: Nihon Kohden provides bedside and central-station patient monitoring with continuous ECG, SpO2, and respiratory monitoring for general wards and ICUs. Its Life Scope and wearable SMS solutions overlap with EarlySense's continuous ward-monitoring use case.
Emerging players
- Biobeat: Biobeat offers a remote patient monitoring platform with chest-worn and wearable sensors that continuously measure vital signs including heart rate, respiratory rate, blood pressure, and temperature. It overlaps with EarlySense in continuous vital-sign monitoring but uses a wearable rather than contact-free form factor.
- iRhythm Technologies: iRhythm's Zio long-term cardiac monitor continuously captures ECG data outside the hospital. It is an emerging adjacent player in continuous ambulatory monitoring, addressing similar "gap between episodic checks" pain points that EarlySense targets on the inpatient side.
- Vivify Health: Vivify Health provides a remote patient monitoring platform used by health systems and payers for post-acute and chronic care management. It is an emerging player whose connected vital-signs kits and RPM workflows are complementary/competing with EarlySense's home-monitoring expansion path.
Broad incumbents
- Philips (Patient Monitoring): Philips Patient Monitoring provides IntelliVue and wearable biosensor solutions across ICU, step-down, and general care. As a global incumbent with broad hospital IT integration, Philips competes directly with EarlySense in continuous ward monitoring while bundling monitoring into larger enterprise contracts.
- GE HealthCare: GE HealthCare's Patient Care Solutions includes bedside monitors, wearable sensors (Portrait Mobile), and central stations for continuous vital signs. It competes with EarlySense in the general-care monitoring category and brings stronger ICU telemetry and EMR integration.
- Mindray: Mindray is a leading global patient monitoring and in-vitro diagnostics vendor with ePM and BeneVision series monitors covering ICU through general wards. It competes with EarlySense on continuous vital signs and benefits from strong price competitiveness, particularly in international markets.
- Drägerwerk: Dräger provides Infinity patient monitoring, anesthesia, and acute-care solutions used in hospitals worldwide. Its general-ward and intermediate-care monitoring competes with EarlySense and adds established ventilator and therapy integration.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
EarlySense social profiles
Digital presenceEarlySense financial estimates
Financial estimateRevenue estimate
Valuation estimate
EarlySense leadership team
Management profileNumber of profiles
Profiles6 records
EarlySense funding detail
Funding detailFunding overview
Funding rounds8 records
Investors17 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
EarlySense M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about EarlySense
What does EarlySense do?
EarlySense develops and sells EverOn, a contact-free continuous patient monitoring system that tracks heart rate, respiratory rate, and motion without physical contact. The system is designed for general care hospital patients, delivering real-time alerts to nursing staff through central stations, large screens, and handheld devices to enable early detection of patient deterioration, fall prevention, and pressure ulcer prevention.
Is EarlySense a public or private company?
EarlySense is a private company. It is classified as venture growth investor backed and is currently operating.
When was EarlySense founded?
EarlySense was founded in 2004. It employs 101 to 250 people.
Where is EarlySense based?
EarlySense is headquartered in Ramat Gan, Israel, in the Middle East region.
How does EarlySense make money?
One revenue line is on record: healthcare Monitoring System Sales.
Who are EarlySense's main competitors?
Direct peers on record are Caretaker Medical, Masimo and Nihon Kohden. Emerging players are Biobeat, iRhythm Technologies and Vivify Health. Broad incumbents are Philips (Patient Monitoring), GE HealthCare, Mindray and Drägerwerk.
Does EarlySense have an API?
No public API is recorded for EarlySense.
What industry is EarlySense in?
EarlySense's product category is Patient Monitoring Systems. Its primary akta.pro industry code is HLAHACAA, Vital Signs Monitoring (Multi-parameter, Spot-Check & Continuous), with a secondary code of HLACAPAI, Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration). Its NAICS code is 334510 and its SIC code is 3845.